Medicines

  1. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €7,700.00
  2. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €3,657.00
  3. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €4,485.00
  4. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,374.25
  5. Beleodaq (belinostat)
    Beleodaq (belinostat)
    by Spectrum Pharmaceuticals, Inc.
    for Lymphoma
    €3,162.50
  6. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €16,847.50
  7. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €3,047.50
  8. Cabometyx (cabozantinib)
    Cabometyx (cabozantinib)
    by Ipsen Pharma
    for Kidney Cancer
    €6,279.00
  9. Calcort (deflazacort)
    Calcort (deflazacort)
    by Merrell Dow/Henning
    for Duchenne Muscular Dystrophy
    €11.44
View as Grid List

Items 1-9 of 52

Page
per page
Set Descending Direction

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.